These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28424418)

  • 1. The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.
    O'Donnell EF; Jang HS; Pearce M; Kerkvliet NI; Kolluri SK
    Oncotarget; 2017 Apr; 8(15):25211-25225. PubMed ID: 28424418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Impairs AhR and ARNT Signaling and Protects Mouse Neuronal Cells Against Hypoxia.
    Rzemieniec J; Litwa E; Wnuk A; Lason W; Krzeptowski W; Kajta M
    Mol Neurobiol; 2016 Oct; 53(8):5591-606. PubMed ID: 26476840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells.
    Schreck I; Chudziak D; Schneider S; Seidel A; Platt KL; Oesch F; Weiss C
    Toxicology; 2009 May; 259(3):91-6. PubMed ID: 19428948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon receptor expression (AhR) in rat liver preneoplastic foci, and in the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2 signaling, and cell cycle regulation in HCB-treated HepG2 cells.
    de Tomaso Portaz AC; Caimi GR; Sánchez M; Chiappini F; Randi AS; Kleiman de Pisarev DL; Alvarez L
    Toxicology; 2015 Oct; 336():36-47. PubMed ID: 26219504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.
    Stejskalova L; Vecerova L; Peréz LM; Vrzal R; Dvorak Z; Nachtigal P; Pavek P
    Toxicol Sci; 2011 Sep; 123(1):26-36. PubMed ID: 21666223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
    Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
    Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.
    O'Donnell EF; Jang HS; Liefwalker DF; Kerkvliet NI; Kolluri SK
    Apoptosis; 2021 Jun; 26(5-6):307-322. PubMed ID: 33893898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.
    Maayah ZH; El Gendy MA; El-Kadi AO; Korashy HM
    Arch Toxicol; 2013 May; 87(5):847-56. PubMed ID: 23288144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation.
    Mezrich JD; Nguyen LP; Kennedy G; Nukaya M; Fechner JH; Zhang X; Xing Y; Bradfield CA
    PLoS One; 2012; 7(9):e44547. PubMed ID: 22970246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
    Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
    Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
    Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq.
    Lo R; Matthews J
    Toxicol Sci; 2012 Dec; 130(2):349-61. PubMed ID: 22903824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells.
    Procházková J; Kozubík A; Machala M; Vondráček J
    Toxicology; 2011 Jan; 279(1-3):146-54. PubMed ID: 20951181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
    Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
    Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid and adrenalectomy effects on the rat aryl hydrocarbon receptor pathway depend on the dosing regimen and post-surgical time.
    Mullen Grey AK; Riddick DS
    Chem Biol Interact; 2009 Dec; 182(2-3):148-58. PubMed ID: 19615983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
    Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
    Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.
    Abdelrahim M; Smith R; Safe S
    Mol Pharmacol; 2003 Jun; 63(6):1373-81. PubMed ID: 12761348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/Enhancer-binding protein-homologous protein sensitizes to SU5416 by modulating p21 and PI3K/Akt signal pathway in FRO anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Horm Metab Res; 2013 Jan; 45(1):9-14. PubMed ID: 22918703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
    Braeuning A; Buchmann A
    Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.